MORF Stock - Morphic Holding, Inc.
Unlock GoAI Insights for MORF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $521,000 | $70.81M | $19.79M | $44.95M | $16.98M |
| Gross Profit | $-570,000 | $69.80M | $18.76M | $-28,685,000 | $-36,755,000 |
| Gross Margin | -109.4% | 98.6% | 94.8% | -63.8% | -216.5% |
| Operating Income | $-178,686,000 | $-63,396,000 | $-95,806,000 | $-47,180,000 | $-46,988,000 |
| Net Income | $-152,095,000 | $-59,041,000 | $-94,240,000 | $-44,999,000 | $-43,328,000 |
| Net Margin | -29192.9% | -83.4% | -476.1% | -100.1% | -255.2% |
| EPS | $-3.59 | $-1.55 | $-2.63 | $-1.47 | $-1.44 |
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; and preclinical trial to treat idiopathic pulmonary fibrosis and fibrosis diseases. The company is also developing avß6 for the treatment of fibrotic diseases, and avß8 to treat solid tumors, as well as various other products. Morphic Holding, Inc. has a research collaboration with Engitix Ltd for the identification of Morphic integrin technology amenable targets in fibrostenotic IBD; a collaboration agreement with Schrödinger, LLC for integrin targets; and a license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. It also has collaboration agreements with AbbVie Biotechnology Ltd and Janssen Pharmaceuticals, Inc. to discover or develop integrin-based therapeutics. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 8th 2023 | Citigroup | Initiation | Buy | $46 |
| September 25th 2023 | Stifel | Reiterated | Hold | $33← $61 |
| September 25th 2023 | BTIG Research | Downgrade | Neutral | - |
| August 9th 2023 | Stifel | Downgrade | Hold | $61← $69 |
| September 7th 2022 | Stifel | Initiation | Buy | $44 |
| July 20th 2022 | SVB Leerink | Initiation | Outperform | $45 |
Earnings History & Surprises
MORFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2024 | Jul 25, 2024 | $-0.96 | $-1.15 | -19.8% | ✗ MISS |
Q2 2024 | Apr 25, 2024 | $-0.96 | $-0.91 | +5.2% | ✓ BEAT |
Q1 2024 | Feb 22, 2024 | $-0.89 | $-0.94 | -5.6% | ✗ MISS |
Q4 2023 | Nov 3, 2023 | $-0.98 | $-0.73 | +25.5% | ✓ BEAT |
Q3 2023 | Aug 3, 2023 | $-0.90 | $-0.92 | -2.2% | ✗ MISS |
Q2 2023 | Apr 25, 2023 | $-0.85 | $-0.90 | -5.9% | ✗ MISS |
Q1 2023 | Feb 23, 2023 | $-0.85 | $-0.64 | +24.7% | ✓ BEAT |
Q4 2022 | Nov 2, 2022 | $-0.80 | $-0.78 | +2.5% | ✓ BEAT |
Q3 2022 | Aug 3, 2022 | $-0.85 | $0.68 | +180.0% | ✓ BEAT |
Q2 2022 | May 4, 2022 | $-0.71 | $-0.85 | -19.7% | ✗ MISS |
Q1 2022 | Feb 24, 2022 | $-0.71 | $-0.57 | +19.7% | ✓ BEAT |
Q4 2021 | Nov 4, 2021 | $-0.76 | $-0.69 | +9.2% | ✓ BEAT |
Q3 2021 | Aug 4, 2021 | $-0.55 | $-0.77 | -40.0% | ✗ MISS |
Q2 2021 | Apr 29, 2021 | $-0.59 | $-0.63 | -6.8% | ✗ MISS |
Q1 2021 | Mar 1, 2021 | $-0.37 | $-0.57 | -54.1% | ✗ MISS |
Q4 2020 | Nov 9, 2020 | $-0.48 | $0.17 | +135.4% | ✓ BEAT |
Q3 2020 | Aug 10, 2020 | $-0.60 | $-0.52 | +13.3% | ✓ BEAT |
Q2 2020 | May 6, 2020 | $-0.56 | $-0.55 | +1.8% | ✓ BEAT |
Q1 2020 | Feb 27, 2020 | $-0.35 | $-0.66 | -88.6% | ✗ MISS |
Q4 2019 | Nov 12, 2019 | $-0.45 | $-0.30 | +33.3% | ✓ BEAT |
Latest News
Frequently Asked Questions about MORF
What is MORF's current stock price?
What is the analyst price target for MORF?
What sector is Morphic Holding, Inc. in?
What is MORF's market cap?
Does MORF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to MORF for comparison